ofloxacin has been researched along with cephalexin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.04) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lipsky, BA; Morman, MR; Powers, RD; Walker, FB; Yarbrough, DR | 1 |
| Powers, RD | 1 |
| Hori, R; Inui, K; Maegawa, H; Okano, T | 1 |
| Braunstajn, Z; Kapidzić, A; Mahmutović, E; Zulić, I | 1 |
| Fujita, K; Horie, N; Katsumata, M; Kukita, A; Nakano, M; Nonami, E; Shishiba, T; Someya, T; Watanabe, R; Watanabe, S | 1 |
| Fujimori, I; Hiraga, Y; Kikuchi, K; Kobayashi, Y; Nakayama, I; Obana, M; Saito, A; Takebe, K; Tomizawa, M; Yamamoto, A | 1 |
| Raz, R; Rozenfeld, S | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Bisharat, N; Gilboa, A; Kennes, Y; Lavi, I; Okev, N; Raz, R | 1 |
| Baĭzakova, GT; Daulbaeva, AA | 1 |
| Ahmadi, AH; Cohen, BE; Shayani, P | 1 |
| Lam, JC; Lam, PK; Leung, HW; Martin, M; Minh, TB; Murphy, MB; Richardson, BJ; So, MK | 1 |
| Chiron, S; de Melo Costa Serge, N; Goetz, V; Li, C; Nogueira, RFP | 1 |
2 review(s) available for ofloxacin and cephalexin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Effect of ozone on antibiotic sensitivity of microorganisms].
Topics: Anti-Bacterial Agents; Bacteria; Cephalexin; Facial Injuries; Humans; Microbial Sensitivity Tests; Neck Injuries; Ofloxacin; Ozone; Wound Healing | 2003 |
6 trial(s) available for ofloxacin and cephalexin
| Article | Year |
|---|---|
Ofloxacin versus cephalexin for treating skin and soft tissue infections.
Topics: Cephalexin; Connective Tissue Diseases; Female; Humans; Male; Ofloxacin; Skin Diseases, Infectious; Treatment Outcome | 1992 |
Soft tissue infections in the emergency department: the case for the use of 'simple' antibiotics.
Topics: Adult; Ambulatory Care; Bacterial Infections; Cephalexin; Connective Tissue Diseases; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies; Skin Diseases, Infectious; Treatment Outcome; Virginia; Wound Infection | 1991 |
[Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Skin Diseases, Infectious; Suppuration | 1984 |
[Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines | 1984 |
3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.
Topics: Aged; Anti-Infective Agents, Urinary; Cephalexin; Cephalosporins; Costs and Cost Analysis; Female; Humans; Middle Aged; Ofloxacin; Postmenopause; Urinary Tract Infections | 1996 |
A prospective study of antibiotic efficacy in preventing infection in reduction mammaplasty.
Topics: Adult; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Female; Humans; Mammaplasty; Ofloxacin; Prospective Studies; Single-Blind Method; Surgical Wound Infection; Wound Healing | 2005 |
15 other study(ies) available for ofloxacin and cephalexin
| Article | Year |
|---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.
Topics: Animals; Cephalexin; Cephradine; Glucose; Kidney; Kidney Cortex; Male; Microvilli; Ofloxacin; p-Aminohippuric Acid; Protons; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds | 1990 |
[Evaluation of the effect of ofloxacin, a new chemotherapeutic agent].
Topics: Adult; Bacterial Infections; Candidiasis, Vulvovaginal; Cephalexin; Female; Genital Diseases, Female; Humans; Ofloxacin | 1988 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bacteriuria; Cephalexin; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infant; Israel; Male; Middle Aged; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; China; Chloramphenicol; Drug Utilization; Environmental Monitoring; Erythromycin; Fluoroquinolones; Hong Kong; Humans; Macrolides; Ofloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Peroxydisulfate activation by CuO pellets in a fixed-bed column, operating mode and assessments for antibiotics degradation and urban wastewater disinfection.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalexin; Clarithromycin; Copper; Disinfection; Escherichia coli; Ofloxacin; Oxidants; Oxides; Phenol; Sulfamethoxazole; Wastewater | 2022 |